1. Home
  2. HFWA vs SVRA Comparison

HFWA vs SVRA Comparison

Compare HFWA & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Heritage Financial Corporation

HFWA

Heritage Financial Corporation

HOLD

Current Price

$27.19

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

SVRA

Savara Inc.

HOLD

Current Price

$6.11

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HFWA
SVRA
Founded
1927
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
1997
2009

Fundamental Metrics

Financial Performance
Metric
HFWA
SVRA
Price
$27.19
$6.11
Analyst Decision
Buy
Buy
Analyst Count
4
9
Target Price
$31.00
$7.33
AVG Volume (30 Days)
249.5K
1.6M
Earning Date
04-23-2026
05-12-2026
Dividend Yield
3.53%
N/A
EPS Growth
58.06
N/A
EPS
1.96
N/A
Revenue
N/A
N/A
Revenue This Year
$45.85
N/A
Revenue Next Year
$7.83
$430.87
P/E Ratio
$13.89
N/A
Revenue Growth
N/A
N/A
52 Week Low
$21.32
$1.89
52 Week High
$28.98
$7.01

Technical Indicators

Market Signals
Indicator
HFWA
SVRA
Relative Strength Index (RSI) 60.76 64.10
Support Level $23.59 $5.86
Resistance Level $28.59 $6.49
Average True Range (ATR) 0.55 0.29
MACD 0.21 0.09
Stochastic Oscillator 70.55 90.29

Price Performance

Historical Comparison
HFWA
SVRA

About HFWA Heritage Financial Corporation

Heritage Financial Corp is a bank holding company. The company, through its subsidiary, provides commercial lending and deposit relationships with small businesses and their owners in its market areas and attracts deposits from the general public. It accepts various deposit products, such as non-interest demand accounts, money market accounts, savings accounts, and certificates of deposit. Besides, the Bank also makes real estate construction loans, land development loans, and consumer loans, and originates first mortgage loans on residential properties mainly located in its market area. Geographically, all the business activity functions through the region of the United States.

About SVRA Savara Inc.

Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).

Share on Social Networks: